Adherence to Chronic Positive Airway Pressure Therapy in Obese Patients With Sleep-disordered Breathing

January 15, 2026 updated by: Anne Kathrine Staehr-Rye
To describe the adherence to positive airway pressure therapy among obese adult patients refered to the respiratory center east

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Glostrup Municipality, Denmark, 2600
        • Respiratory Center East, Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Respiratory center east,

Description

Inclusion Criteria:

  • 18 years or older
  • Body mass index above 30 kg/m2
  • Referred to the Respiratory Center East between january 2021 and january 2024

Exclusion Criteria:

  • Neuromuscular disease
  • Spinal cord injury
  • Craniofacial malformation
  • Scoliosis
  • Diaphragmatic paresis
  • Referred to profylactic secrete management only
  • Already in treatment with nPAP with use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period during the last 90 days.
  • No medical indication for start of nPAP.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance to noninvasive positive airway pressure therapy (nPAP) - 90 days
Time Frame: 0-3 months after start of noninvasive positive airway pressure therapy
Use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period within the first 90 days of having the equipment.
0-3 months after start of noninvasive positive airway pressure therapy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 1 year
Mortality up to 1 year after initiation of noninvasive positive airway pressure therapy
1 year
Compliance to noninvasive positive airway pressure therapy (nPAP) - 1 year
Time Frame: Time Frame: 275 to 365 day after start of noninvasive positive airway pressure therapy
Use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period within the 275 to 365 day of having the equipment.
Time Frame: 275 to 365 day after start of noninvasive positive airway pressure therapy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Anne Kathrine Staehr-Rye

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

April 1, 2025

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

January 2, 2026

First Submitted That Met QC Criteria

January 15, 2026

First Posted (Actual)

January 23, 2026

Study Record Updates

Last Update Posted (Actual)

January 23, 2026

Last Update Submitted That Met QC Criteria

January 15, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • p-2025-20420

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Positive Airway Pressure Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe